Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea · Delayed Price · Currency is KRW 989.00
-11.00 (-1.10%)
At close: Aug 1, 2025, 3:30 PM KST
Achilles Therapeutics Market Cap
Kainos Medicine has a market cap or net worth of 32.76 billion as of August 8, 2025. Its market cap has decreased by -73.55% in one year.
Market Cap
32.76B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
160.23
Stock Price
$989.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 32.76B, a decrease of -92.46%. That is a compound annual growth rate of -39.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 32.76B | -63.33% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
| Jun 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 460.93T |
| SK hynix | 177.07T |
| LG Energy Solution | 88.57T |
| Samsung Biologics | 73.24T |
| Hyundai Motor Company | 46.44T |
| Hanwha Aerospace | 45.33T |
| Doosan Enerbility | 42.53T |
| HD Hyundai Heavy Industries | 41.41T |